Griffin J Frank T, Spittle Evelyn, Rodgers Christie R, Liggett Simon, Cooper Marc, Bakker Douwe, Bannantine John P
Disease Research Laboratory, Department of Microbiology and Immunology, University of Otago, PO Box 56, Dunedin, New Zealand.
Clin Diagn Lab Immunol. 2005 Dec;12(12):1401-9. doi: 10.1128/CDLI.12.12.1401-1409.2005.
This study was designed to develop a customized enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of Johne's disease (JD) in farmed deer. Two antigens were selected on the basis of their superior diagnostic readouts: denatured purified protein derivative (PPDj) and undenatured protoplasmic antigen (PpAg). ELISA development was based on the antigen reactivity of the immunoglobulin G1 (IgG1) isotype, which is a highly specific marker for mycobacterial disease seroreactivity in deer. Sensitivity estimates and test parameters were established using 102 Mycobacterium paratuberculosis-infected animals from more than 10 deer herds, and specificity estimates were determined using 508 uninfected animals from 5 known disease-free herds. A receiver-operated characteristic analysis determined that at a cut point of 50 ELISA units, there was a specificity of 99.5% and sensitivities of 84.0% with PPDj antigen, 88.0% with PpAg, and 91.0% when the antigens were used serially in a composite test. Estimated sensitivity was further improved using recombinant protein antigens unique for M. paratuberculosis, which identified infected animals that were unreactive to PPDj or PpAg. While 80% of animals that were seropositive in the IgG1 ELISA had detectable histopathology, the assay could also detect animals with subclinical disease. The test was significantly less sensitive (75%) for animals that were culture positive for M. paratuberculosis but with no detectable pathology than for those with pathological evidence of JD (>90%). When the IgG1 ELISA was used annually over a 4-year period in a deer herd with high levels of clinical JD, it eliminated clinical disease, increased production levels, and reduced JD-related mortality.
本研究旨在开发一种定制的酶联免疫吸附测定(ELISA)方法,用于养殖鹿群中副结核病(JD)的血清学诊断。基于其优越的诊断结果,选择了两种抗原:变性纯化蛋白衍生物(PPDj)和未变性原生质抗原(PpAg)。ELISA的开发基于免疫球蛋白G1(IgG1)同种型的抗原反应性,IgG1是鹿分枝杆菌病血清反应性的高度特异性标志物。使用来自10多个鹿群的102只感染副结核分枝杆菌的动物确定敏感性估计值和测试参数,并使用来自5个已知无病鹿群的508只未感染动物确定特异性估计值。受试者工作特征分析确定,在ELISA单位为50的切点时,使用PPDj抗原的特异性为99.5%,敏感性为84.0%;使用PpAg抗原的敏感性为88.0%;当两种抗原在复合试验中连续使用时,敏感性为91.0%。使用副结核分枝杆菌特有的重组蛋白抗原进一步提高了估计的敏感性,该重组蛋白抗原可识别对PPDj或PpAg无反应的感染动物。虽然在IgG1 ELISA中呈血清阳性的动物中有80%具有可检测到的组织病理学变化,但该检测方法也能检测出患有亚临床疾病的动物。对于副结核分枝杆菌培养呈阳性但无明显病理学变化的动物,该检测的敏感性(75%)明显低于有JD病理学证据的动物(>90%)。当在一个临床JD水平较高的鹿群中每年使用IgG1 ELISA进行为期4年的检测时,它消除了临床疾病,提高了生产水平,并降低了与JD相关的死亡率。